Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Molly A. Holman | M | - |
Metabasis Therapeutics, Inc.
 Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Metabasis Therapeutics, Inc. engages in discovery, development and commercialization of novel drugs for metabolic diseases using the proprietary technology and the knowledge of processes and pathways within the liver that are useful for liver-selective drug targeting and treatment of metabolic diseases. Metabasis was incorporated in April 1997 and is headquartered in La Jolla, CA. | 16 years |
| James Matteucci | M | - | 21 years | |
| Steven Graziano | M | - | 18 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Robert P. Luciano | M | - | 23 years | |
| Richard Kogan | M | 81 | 21 years | |
| Tran Nguyen | M | 50 |
Metabasis Therapeutics, Inc.
Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Metabasis Therapeutics, Inc. engages in discovery, development and commercialization of novel drugs for metabolic diseases using the proprietary technology and the knowledge of processes and pathways within the liver that are useful for liver-selective drug targeting and treatment of metabolic diseases. Metabasis was incorporated in April 1997 and is headquartered in La Jolla, CA. | 1 years |
| John W. Beck | M | 64 |
Metabasis Therapeutics, Inc.
Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Metabasis Therapeutics, Inc. engages in discovery, development and commercialization of novel drugs for metabolic diseases using the proprietary technology and the knowledge of processes and pathways within the liver that are useful for liver-selective drug targeting and treatment of metabolic diseases. Metabasis was incorporated in April 1997 and is headquartered in La Jolla, CA. | 10 years |
| Richard Clark | M | 77 | 6 years | |
| Fred Hassan | M | 78 | 6 years | |
| Thomas Shenk | M | 77 | 11 years | |
| Peter Wendell | M | 73 | 21 years | |
| Charles Kidder | M | 79 | 12 years | |
| Steven Goldstone | M | 78 | 6 years | |
| David Anstice | M | 75 | 5 years | |
| Rochelle Lazarus | F | 76 | 16 years | |
| Wendell Weeks | M | 64 | 16 years | |
| Ismail Kola | M | 67 | 4 years | |
| Natarajan Sethuraman | M | 62 | 10 years | |
| Nancy Thornberry | F | 67 | 9 years | |
| Peter Honig | M | 67 | 7 years | |
| Glenn Dourado | M | - |
Metabasis Therapeutics, Inc.
Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Metabasis Therapeutics, Inc. engages in discovery, development and commercialization of novel drugs for metabolic diseases using the proprietary technology and the knowledge of processes and pathways within the liver that are useful for liver-selective drug targeting and treatment of metabolic diseases. Metabasis was incorporated in April 1997 and is headquartered in La Jolla, CA. | 5 years |
| Pernilla Sandwall | F | 61 | 8 years | |
| Vijay Tammara | M | 64 | 6 years | |
| Robert W. Verdugo | M | - | 3 years | |
| Richard Pasternak | M | 75 | 4 years | |
| Mark C. Twyman | M | 63 | 18 years | |
| Scott J. Hecker | M | - |
Metabasis Therapeutics, Inc.
Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Metabasis Therapeutics, Inc. engages in discovery, development and commercialization of novel drugs for metabolic diseases using the proprietary technology and the knowledge of processes and pathways within the liver that are useful for liver-selective drug targeting and treatment of metabolic diseases. Metabasis was incorporated in April 1997 and is headquartered in La Jolla, CA. | 6 years |
| Scott Anthony Climes | M | 59 | 16 years | |
| Simon D. Kelner | M | 51 | 13 years | |
| Marcus Cantillon | M | 66 | 4 years | |
| Zhi Sheng Chen | M | 52 | 5 years | |
| Peter Haeberli | M | - | - | |
| Eduardo O. Thompson | M | - | 6 years | |
| Kevin J. Horgan | M | 64 | 8 years | |
| Eric Schadt | M | 59 | 8 years | |
| Desiree Ralls-Morrison | F | 57 | 8 years | |
| Barbara Yanni | F | 69 | 13 years | |
| Daniel Pascheles | M | - | 11 years | |
| Kevin Oliver | M | - | 9 years | |
| Edward Berg | M | 60 | 8 years | |
| John Renger | M | 55 | 15 years | |
| David Ege | M | 50 | 16 years | |
| Kimberly Murphy | F | 62 | 6 years | |
| Joel Lebowitz | M | 60 | 9 years | |
| Judith C. Seltz | F | 61 | 15 years | |
| Jens Renstrup | M | 59 | 8 years | |
| Mark Talens | M | - | - | |
| Sandra Gurrola | F | 57 |
Metabasis Therapeutics, Inc.
Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Metabasis Therapeutics, Inc. engages in discovery, development and commercialization of novel drugs for metabolic diseases using the proprietary technology and the knowledge of processes and pathways within the liver that are useful for liver-selective drug targeting and treatment of metabolic diseases. Metabasis was incorporated in April 1997 and is headquartered in La Jolla, CA. | 2 years |
| Craig Buchholz | M | - | 9 years | |
| James Swanson | M | 58 | 8 years | |
| Maarten van der Linden | M | 55 | 4 years | |
| Alexis Ji | M | - | 5 years | |
| Weichang Zhou | M | 59 | 8 years | |
| Elizabeth Stoner | M | 73 |
Metabasis Therapeutics, Inc.
Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Metabasis Therapeutics, Inc. engages in discovery, development and commercialization of novel drugs for metabolic diseases using the proprietary technology and the knowledge of processes and pathways within the liver that are useful for liver-selective drug targeting and treatment of metabolic diseases. Metabasis was incorporated in April 1997 and is headquartered in La Jolla, CA. | 1 years |
| Mark Shearman | M | 62 | 3 years | |
| Jacob Harel | M | 69 | 13 years | |
| Christine Bunt | F | - | 7 years | |
| Misti Ushio | M | 53 | 10 years | |
| Wendy Perrow | F | 66 | 14 years | |
| Bruce N. Kuhlik | M | 67 | 10 years | |
| David S. Doll | M | - | 8 years | |
| George F. Schreiner | M | 74 |
Metabasis Therapeutics, Inc.
Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Metabasis Therapeutics, Inc. engages in discovery, development and commercialization of novel drugs for metabolic diseases using the proprietary technology and the knowledge of processes and pathways within the liver that are useful for liver-selective drug targeting and treatment of metabolic diseases. Metabasis was incorporated in April 1997 and is headquartered in La Jolla, CA. | 3 years |
| Erskine B. Bowles | M | 78 | 2 years | |
| Larry Bossidy | M | 89 | 14 years | |
| Heidi Miller | M | 70 | 4 years | |
| Pam Cheng | F | 53 | 5 years | |
| Patricia Millican | F | 51 |
Metabasis Therapeutics, Inc.
Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Metabasis Therapeutics, Inc. engages in discovery, development and commercialization of novel drugs for metabolic diseases using the proprietary technology and the knowledge of processes and pathways within the liver that are useful for liver-selective drug targeting and treatment of metabolic diseases. Metabasis was incorporated in April 1997 and is headquartered in La Jolla, CA. | 3 years |
| Hugh Johnston | M | 62 | 3 years | |
| Heinz W. Gschwend | M | - |
Metabasis Therapeutics, Inc.
Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Metabasis Therapeutics, Inc. engages in discovery, development and commercialization of novel drugs for metabolic diseases using the proprietary technology and the knowledge of processes and pathways within the liver that are useful for liver-selective drug targeting and treatment of metabolic diseases. Metabasis was incorporated in April 1997 and is headquartered in La Jolla, CA. | - |
| Sujay Kango | M | 60 | 5 years | |
| Mark A. Varney | M | 57 | 4 years | |
| James Christopher Scalet | M | 65 | 9 years | |
| Willie Deese | M | 68 | 12 years | |
| David Arkowitz | M | 62 | 3 years | |
| Joan Wainwright | F | 63 | 6 years | |
| Wendy Dixon | M | 68 | 5 years | |
| Paul Howes | M | 69 | 5 years | |
| Peter D. Löscher | M | 66 | 1 years | |
| Ben Shapiro | M | 84 | 13 years | |
| François Martelet | M | 64 | 2 years | |
| Bernard J. Kelley | M | 82 | 10 years | |
| Jim Hinrichs | M | 56 | 5 years | |
| Gerald L. Wisler | M | 67 | 20 years | |
| Franz Hefti | M | 76 | 7 years | |
| Mirian Graddick-Weir | M | 69 | 12 years | |
| Raymond F. Kerins | M | - | 1 years | |
| John Z. Sullivan-Bólyai | M | 76 | 11 years | |
| Penny M. Heaton | M | 59 | 7 years | |
| Thomas Martin Vernon | M | 85 | - | |
| Steven Nichtberger | M | 62 | 8 years | |
| Guy MacDonald | M | 65 | 22 years | |
| Paul Ronald Bell | M | 76 | 14 years | |
| Ed M. Scolnick | M | 83 | 20 years | |
| Ian M. Miller | M | - | 11 years | |
| Vincent Lawton | M | 75 | - | |
| Howard L. Foyt | M | 69 |
Metabasis Therapeutics, Inc.
Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Metabasis Therapeutics, Inc. engages in discovery, development and commercialization of novel drugs for metabolic diseases using the proprietary technology and the knowledge of processes and pathways within the liver that are useful for liver-selective drug targeting and treatment of metabolic diseases. Metabasis was incorporated in April 1997 and is headquartered in La Jolla, CA. | 2 years |
| Steven Kelmar | M | 70 | 3 years | |
| John Kelly | M | 57 | 9 years | |
| Linda Burns | F | - | 1 years | |
| Sean Dobson | M | - | 5 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Barry Gumbiner
- Personal Network